(Q72660849)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6175043%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Antithrombin BM from human plasma: an antithrombin binding moderately to heparin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6175043%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Antithrombin bm from human plasma: An antithrombin binding moderately to heparin (English)

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

21 August 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6175043

21 August 2023

author name string

P. Wunderwald

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6175043

21 August 2023

W. J. Schrenk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6175043

21 August 2023

H. Port

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6175043

21 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6175043

21 August 2023

publication date

1 February 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6175043%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.elsevier.com/content/article/PII:0049384882902377?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

https://api.elsevier.com/content/article/PII:0049384882902377?httpAccept=text/plain

21 August 2023

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

21 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6175043%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6175043%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6175043%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

177-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6175043%20AND%20SRC:MED&resulttype=core&format=json

Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis

28 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Antithrombin III and Diseases

21 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Minimal Heparin Cofactor Activity in Disseminated Intravascular Coagulation and Cirrhosis

21 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Heparin cofactor and plasma antithrombin in relation to the mechanism of inactivation of thrombin by heparin

21 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Electrophoretic Separation of Two Thrombin Inhibitors in Plasma and Serum

21 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Identification of two distinct heparin cofactors in human plasma. II. Inhibition of thrombin and activated factor X.

21 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

The anticoagulant effect of heparan sulfate and dermatan sulfate

21 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Involvement of antithrombin III in anticoagulant effects of sulphated polysaccharides

21 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Plasminogen: Purification from Human Plasma by Affinity Chromatography

21 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Bovine factor X (Stuart factor)

21 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Antigen-antibody reactions in gels

21 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Two-dimensional electrophoresis of protein antigens with an antibody containing buffer

21 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Heparin cofactor activity measured with an amidolytic method

21 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

The assay of antithrombin using a synthetic chromogenic substrate for thrombin

21 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Interaction of heparin with thrombin and antithrombin III

21 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Chemistry of the hemostatic mechanism and its relationship to the action of heparin

21 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

21 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Isolation and Characterization of Heparin from Human Lung

21 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Heparin: An Old Drug with a New Paradigm

21 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Enhancement of antithrombin III activity by carrageenans

21 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Effects of a sulphated xylan on aggregation of human blood platelets

21 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

New heparin-like insoluble materials: Part I

21 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

α2-Macroglobulin as Progressive Antithrombin

21 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

The antithrombin and antiheparin effects of crude and highly purified alpha 1-acid glycoprotein

21 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells

21 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Properties of antithrombin III depleted plasma. I. Effect of heparin

21 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatography

21 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0049-3848(82)90237-7

21 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6175043%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference